📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Oncovision

1.1 - Company Overview

Oncovision Logo

Oncovision

Headquarter: Mexico
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of molecular vision solutions for the health sciences sector, supporting cancer diagnosis and treatment and advanced research in neurology, oncology, and cardiology. Spanish technology start-up founded in 2003 by the Corpuscular Physics Institute (CSIC) and the University of Valencia.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Oncovision

GamaMabs Logo

GamaMabs

HQ: France Website
  • Description: Provider of optimized monoclonal antibody therapeutics for cancer, developing clinical-stage immuno-oncology candidates including GM102 (formerly 3C23K), a mAb targeting the anti-Müllerian hormone receptor (AMHR2) in gynecological cancers, currently in phase Ia/Ib.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GamaMabs company profile →
DiaCarta Logo

DiaCarta

HQ: United States Website
  • Description: Provider of precision molecular diagnostics, including CE/IVD-marked KRAS detection, for cancer screening, monitoring, and therapy guidance. Offerings include RadTox for real-time cfDNA treatment response; ColoScape for colorectal screening and FIT-positive triage via plasma cfDNA changes; QClamp for sensitive ctDNA mutation detection; OptiSeq Colorectal Cancer NGS Panel for actionable mutations; Oncuria urine biomarkers; and custom mini-MRD panels.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DiaCarta company profile →
Phoenix Biotechnology Logo

Phoenix Biotechnology

HQ: United States Website
  • Description: Provider of research and development of therapeutic agents and treatment regimens for cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phoenix Biotechnology company profile →
CarThera Logo

CarThera

HQ: France Website
  • Description: Provider of therapeutic ultrasound-based medical devices for treating brain disorders, including SonoCloud, an intracranial implant that uses low-intensity pulsed ultrasound to temporarily open the blood-brain barrier for enhanced delivery of therapeutic agents, and SonoCloud-9, a nine-emitter version to open larger regions; also conducts preclinical and clinical R&D combining SonoCloud with therapeutic agents to treat brain tumors and neurodegenerative diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CarThera company profile →
Profound Medical Logo

Profound Medical

HQ: Canada Website
  • Description: Provider of medical device solutions for MRI-guided ablation in prostate care, offering TULSA-PRO, a transurethral ultrasound ablation system under MRI guidance; Sonalleve, a HIFU therapy platform for non-invasive treatment of uterine fibroids and palliative bone metastases pain; and PRO-Talk, an educational platform with learning resources for physicians.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Profound Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Oncovision

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Oncovision

2.2 - Growth funds investing in similar companies to Oncovision

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Oncovision

4.2 - Public trading comparable groups for Oncovision

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Oncovision

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Oncovision

What does Oncovision do?

Oncovision is a provider of molecular vision solutions for the health sciences sector, supporting cancer diagnosis and treatment and advanced research in neurology, oncology, and cardiology. Spanish technology start-up founded in 2003 by the Corpuscular Physics Institute (CSIC) and the University of Valencia.

Who are Oncovision's competitors?

Oncovision's competitors and similar companies include GamaMabs, DiaCarta, Phoenix Biotechnology, CarThera, and Profound Medical.

Where is Oncovision headquartered?

Oncovision is headquartered in Mexico.

How many employees does Oncovision have?

Oncovision has 1,000 employees 🔒.

When was Oncovision founded?

Oncovision was founded in 2010 🔒.

What sector and industry vertical is Oncovision in?

Oncovision is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Oncovision

Who are the top strategic acquirers in Oncovision's sector and industry

Top strategic M&A buyers and acquirers in Oncovision's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Oncovision?

Top strategic M&A buyers groups and sectors for Oncovision include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Oncovision's sector and industry vertical

Which are the top PE firms investing in Oncovision's sector and industry vertical?

Top PE firms investing in Oncovision's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Oncovision's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Oncovision's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Oncovision's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Oncovision include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Oncovision's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Oncovision?

The key public trading comparables and valuation benchmarks for Oncovision include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Oncovision for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Oncovision with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Oncovision's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Oncovision with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Oncovision's' sector and industry vertical?

Access recent funding rounds and capital raises in Oncovision's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Oncovision